Annual FCF:
-$352.74M+$235.59M(+40.04%)Summary
- As of today, SRPT annual free cash flow is -$352.74 million, with the most recent change of +$235.59 million (+40.04%) on December 31, 2024.
- During the last 3 years, SRPT annual free cash flow has risen by +$131.23 million (+27.11%).
- SRPT annual free cash flow is now -1496.23% below its all-time high of $25.26 million, reached on December 31, 2020.
Performance
SRPT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$55.62M-$284.97M(-124.25%)Summary
- As of today, SRPT quarterly free cash flow is -$55.62 million, with the most recent change of -$284.97 million (-124.25%) on September 30, 2025.
- Over the past year, SRPT quarterly free cash flow has increased by +$52.34 million (+48.48%).
- SRPT quarterly free cash flow is now -108.99% below its all-time high of $618.67 million, reached on March 31, 2020.
Performance
SRPT Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$401.63M+$52.34M(+11.53%)Summary
- As of today, SRPT TTM free cash flow is -$401.63 million, with the most recent change of +$52.34 million (+11.53%) on September 30, 2025.
- Over the past year, SRPT TTM free cash flow has increased by +$78.78 million (+16.40%).
- SRPT TTM free cash flow is now -255.36% below its all-time high of $258.51 million, reached on March 31, 2020.
Performance
SRPT TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SRPT Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +40.0% | +48.5% | +16.4% |
| 3Y3 Years | +27.1% | +24.0% | -39.8% |
| 5Y5 Years | +31.6% | +78.9% | -1056.6% |
SRPT Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +40.0% | -124.3% | +91.2% | -39.8% | +42.4% |
| 5Y | 5-Year | -1496.2% | +40.0% | -124.3% | +91.2% | -1056.6% | +49.7% |
| All-Time | All-Time | -1496.2% | +40.0% | -109.0% | +91.2% | -255.4% | +49.7% |
SRPT Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$55.62M(-124.2%) | -$401.63M(+11.5%) |
| Jun 2025 | - | $229.35M(+136.4%) | -$453.97M(+34.9%) |
| Mar 2025 | - | -$629.33M(-1266.2%) | -$697.55M(-97.7%) |
| Dec 2024 | -$352.74M(+40.0%) | $53.96M(+150.0%) | -$352.74M(+26.6%) |
| Sep 2024 | - | -$107.96M(-659.0%) | -$480.40M(+9.0%) |
| Jun 2024 | - | -$14.22M(+95.0%) | -$528.06M(+19.3%) |
| Mar 2024 | - | -$284.52M(-286.1%) | -$653.98M(-11.2%) |
| Dec 2023 | -$588.34M(-64.5%) | -$73.70M(+52.6%) | -$588.34M(+4.3%) |
| Sep 2023 | - | -$155.62M(-11.0%) | -$615.00M(-15.5%) |
| Jun 2023 | - | -$140.14M(+36.0%) | -$532.58M(-13.7%) |
| Mar 2023 | - | -$218.88M(-118.1%) | -$468.32M(-31.5%) |
| Dec 2022 | -$357.60M(+26.1%) | -$100.36M(-37.1%) | -$356.17M(-24.0%) |
| Sep 2022 | - | -$73.19M(+3.6%) | -$287.35M(+17.4%) |
| Jun 2022 | - | -$75.89M(+28.9%) | -$347.72M(+10.1%) |
| Mar 2022 | - | -$106.73M(-238.5%) | -$386.87M(+19.7%) |
| Dec 2021 | -$483.97M(-2015.7%) | -$31.53M(+76.4%) | -$481.66M(+26.7%) |
| Sep 2021 | - | -$133.57M(-16.1%) | -$656.77M(+16.5%) |
| Jun 2021 | - | -$115.04M(+42.9%) | -$786.69M(+1.5%) |
| Mar 2021 | - | -$201.52M(+2.5%) | -$798.43M(-3768.6%) |
| Dec 2020 | $25.26M(+104.9%) | -$206.65M(+21.6%) | $21.76M(-48.2%) |
| Sep 2020 | - | -$263.49M(-107.8%) | $41.99M(-81.6%) |
| Jun 2020 | - | -$126.77M(-120.5%) | $228.02M(-11.8%) |
| Mar 2020 | - | $618.67M(+431.9%) | $258.51M(+149.4%) |
| Dec 2019 | -$516.09M(-14.7%) | -$186.42M(-140.7%) | -$523.51M(-9.0%) |
| Sep 2019 | - | -$77.45M(+19.6%) | -$480.27M(+10.6%) |
| Jun 2019 | - | -$96.28M(+41.1%) | -$537.30M(+5.4%) |
| Mar 2019 | - | -$163.35M(-14.1%) | -$567.85M(-25.4%) |
| Dec 2018 | -$449.82M(-77.6%) | -$143.18M(-6.5%) | -$453.00M(-31.2%) |
| Sep 2018 | - | -$134.49M(-6.0%) | -$345.41M(-24.9%) |
| Jun 2018 | - | -$126.83M(-161.5%) | -$276.58M(-16.2%) |
| Mar 2018 | - | -$48.51M(-36.3%) | -$238.12M(+6.0%) |
| Dec 2017 | -$253.21M(-0.2%) | -$35.58M(+45.8%) | -$253.21M(+16.2%) |
| Sep 2017 | - | -$65.66M(+25.7%) | -$302.21M(-1.3%) |
| Jun 2017 | - | -$88.37M(-39.0%) | -$298.33M(-17.4%) |
| Mar 2017 | - | -$63.60M(+24.8%) | -$254.02M(-0.5%) |
| Dec 2016 | -$252.69M(-63.8%) | -$84.58M(-36.9%) | -$252.69M(-25.8%) |
| Sep 2016 | - | -$61.78M(-40.2%) | -$200.91M(-7.5%) |
| Jun 2016 | - | -$44.06M(+29.2%) | -$186.94M(-8.5%) |
| Mar 2016 | - | -$62.27M(-89.8%) | -$172.29M(-11.7%) |
| Dec 2015 | -$154.30M(+0.7%) | -$32.81M(+31.4%) | -$154.30M(-2.6%) |
| Sep 2015 | - | -$47.80M(-62.5%) | -$150.40M(+0.3%) |
| Jun 2015 | - | -$29.42M(+33.6%) | -$150.81M(+9.0%) |
| Mar 2015 | - | -$44.27M(-53.1%) | -$165.75M(-6.7%) |
| Dec 2014 | -$155.36M(-126.9%) | -$28.91M(+40.1%) | -$155.36M(-7.1%) |
| Sep 2014 | - | -$48.22M(-8.7%) | -$145.01M(-22.5%) |
| Jun 2014 | - | -$44.35M(-30.9%) | -$118.35M(-36.2%) |
| Mar 2014 | - | -$33.88M(-82.6%) | -$86.89M(-26.9%) |
| Dec 2013 | -$68.47M(-122.0%) | -$18.55M(+13.9%) | -$68.47M(-19.1%) |
| Sep 2013 | - | -$21.55M(-67.1%) | -$57.50M(-31.2%) |
| Jun 2013 | - | -$12.90M(+16.6%) | -$43.83M(-18.5%) |
| Mar 2013 | - | -$15.46M(-104.0%) | -$36.99M(-19.9%) |
| Dec 2012 | -$30.84M(-18.7%) | -$7.58M(+3.9%) | -$30.84M(-3.9%) |
| Sep 2012 | - | -$7.89M(-30.1%) | -$29.69M(-0.1%) |
| Jun 2012 | - | -$6.06M(+34.9%) | -$29.65M(-19.1%) |
| Mar 2012 | - | -$9.31M(-44.8%) | -$24.89M(+4.2%) |
| Dec 2011 | -$25.98M | -$6.43M(+18.0%) | -$25.98M(-18.4%) |
| Sep 2011 | - | -$7.84M(-500.1%) | -$21.95M(-26.4%) |
| Jun 2011 | - | -$1.31M(+87.4%) | -$17.36M(+16.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | -$10.40M(-334.7%) | -$20.75M(-20.9%) |
| Dec 2010 | -$17.16M(-59.0%) | -$2.39M(+26.6%) | -$17.16M(-2.2%) |
| Sep 2010 | - | -$3.26M(+30.5%) | -$16.79M(-7.6%) |
| Jun 2010 | - | -$4.69M(+31.1%) | -$15.60M(+0.6%) |
| Mar 2010 | - | -$6.82M(-236.8%) | -$15.70M(-45.4%) |
| Dec 2009 | -$10.79M(+20.4%) | -$2.02M(+2.1%) | -$10.79M(+7.6%) |
| Sep 2009 | - | -$2.07M(+56.8%) | -$11.68M(+16.7%) |
| Jun 2009 | - | -$4.79M(-150.7%) | -$14.02M(-31.0%) |
| Mar 2009 | - | -$1.91M(+34.3%) | -$10.70M(+21.1%) |
| Dec 2008 | -$13.56M(+49.4%) | -$2.91M(+34.0%) | -$13.56M(+25.9%) |
| Sep 2008 | - | -$4.41M(-198.8%) | -$18.30M(+3.0%) |
| Jun 2008 | - | -$1.47M(+69.0%) | -$18.87M(+24.4%) |
| Mar 2008 | - | -$4.76M(+37.7%) | -$24.96M(+4.6%) |
| Dec 2007 | -$26.80M(-21.5%) | -$7.65M(-53.8%) | -$26.15M(-10.4%) |
| Sep 2007 | - | -$4.97M(+34.3%) | -$23.68M(+3.5%) |
| Jun 2007 | - | -$7.57M(-27.0%) | -$24.55M(-12.3%) |
| Mar 2007 | - | -$5.96M(-15.1%) | -$21.86M(-2.2%) |
| Dec 2006 | -$22.07M(-36.8%) | -$5.18M(+11.4%) | -$21.38M(-1.1%) |
| Sep 2006 | - | -$5.84M(-19.8%) | -$21.15M(-28.5%) |
| Jun 2006 | - | -$4.88M(+11.0%) | -$16.46M(+0.7%) |
| Mar 2006 | - | -$5.48M(-10.8%) | -$16.58M(-5.3%) |
| Dec 2005 | -$16.14M(+35.1%) | -$4.95M(-330.2%) | -$15.74M(-8.7%) |
| Sep 2005 | - | -$1.15M(+77.0%) | -$14.48M(+25.5%) |
| Jun 2005 | - | -$5.00M(-7.5%) | -$19.43M(+10.1%) |
| Mar 2005 | - | -$4.65M(-26.0%) | -$21.62M(+13.0%) |
| Dec 2004 | -$24.85M(-30.0%) | -$3.69M(+39.5%) | -$24.85M(+4.8%) |
| Sep 2004 | - | -$6.10M(+15.1%) | -$26.10M(-10.3%) |
| Jun 2004 | - | -$7.19M(+8.8%) | -$23.67M(-19.1%) |
| Mar 2004 | - | -$7.88M(-59.5%) | -$19.87M(-3.9%) |
| Dec 2003 | -$19.12M(+17.0%) | -$4.94M(-34.6%) | -$19.12M(-2.6%) |
| Sep 2003 | - | -$3.67M(-8.3%) | -$18.63M(+4.8%) |
| Jun 2003 | - | -$3.39M(+52.5%) | -$19.56M(+21.3%) |
| Mar 2003 | - | -$7.13M(-60.2%) | -$24.84M(-7.8%) |
| Dec 2002 | -$23.04M(-35.5%) | -$4.45M(+3.3%) | -$23.04M(+4.3%) |
| Sep 2002 | - | -$4.60M(+46.9%) | -$24.08M(-3.7%) |
| Jun 2002 | - | -$8.67M(-62.9%) | -$23.21M(-25.4%) |
| Mar 2002 | - | -$5.32M(+2.9%) | -$18.51M(-8.9%) |
| Dec 2001 | -$17.00M(-71.0%) | -$5.48M(-46.7%) | -$17.00M(-12.5%) |
| Sep 2001 | - | -$3.74M(+5.8%) | -$15.11M(-12.9%) |
| Jun 2001 | - | -$3.97M(-4.2%) | -$13.38M(-9.0%) |
| Mar 2001 | - | -$3.81M(-5.9%) | -$12.28M(-23.5%) |
| Dec 2000 | -$9.94M(-27.5%) | -$3.60M(-79.2%) | -$9.94M(-21.0%) |
| Sep 2000 | - | -$2.01M(+29.9%) | -$8.22M(-1.6%) |
| Jun 2000 | - | -$2.86M(-94.2%) | -$8.09M(-8.6%) |
| Mar 2000 | - | -$1.47M(+21.4%) | -$7.45M(+3.2%) |
| Dec 1999 | -$7.80M(+13.3%) | -$1.87M(+0.3%) | -$7.70M(+5.0%) |
| Sep 1999 | - | -$1.88M(+15.3%) | -$8.10M(-24.4%) |
| Jun 1999 | - | -$2.22M(-28.8%) | -$6.51M(+2.5%) |
| Mar 1999 | - | -$1.72M(+24.4%) | -$6.68M(+2.4%) |
| Dec 1998 | -$9.00M(-172.7%) | -$2.28M(-681.8%) | -$6.85M(-16.7%) |
| Sep 1998 | - | -$291.50K(+87.8%) | -$5.87M(+10.8%) |
| Jun 1998 | - | -$2.39M(-26.5%) | -$6.58M(-40.3%) |
| Mar 1998 | - | -$1.89M(-45.2%) | -$4.69M(-42.1%) |
| Dec 1997 | -$3.30M(-94.1%) | -$1.30M(-30.0%) | -$3.30M(-65.0%) |
| Sep 1997 | - | -$1.00M(-100.0%) | -$2.00M(-100.0%) |
| Jun 1997 | - | -$500.00K(0.0%) | -$1.00M(-100.0%) |
| Mar 1997 | - | -$500.00K | -$500.00K |
| Dec 1996 | -$1.70M | - | - |
FAQ
- What is Sarepta Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Sarepta Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Sarepta Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Sarepta Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of SRPT is -$352.74M
What is the all-time high annual free cash flow for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high annual free cash flow is $25.26M
What is Sarepta Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, SRPT annual free cash flow has changed by +$235.59M (+40.04%)
What is Sarepta Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of SRPT is -$55.62M
What is the all-time high quarterly free cash flow for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high quarterly free cash flow is $618.67M
What is Sarepta Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, SRPT quarterly free cash flow has changed by +$52.34M (+48.48%)
What is Sarepta Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of SRPT is -$401.63M
What is the all-time high TTM free cash flow for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high TTM free cash flow is $258.51M
What is Sarepta Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, SRPT TTM free cash flow has changed by +$78.78M (+16.40%)